Search

Author/Creator Sinz, Michael

1. Development of BET inhibitors as potential treatments for cancer: A new carboline chemotype. (1st November 2021)

Authors:
Hill, Matthew D.; Quesnelle, Claude; Tokarski, John; Fang, Haiquan; Fanslau, Carolynn; Haarhoff, Zuzana; Kramer, Melissa; Madari, Shilpa; Wiebesiek, Amy; Morrison, John; Simmermacher-Mayer, Jean; Sinz, Michael; Westhouse, Richard; Xie, Chunshan; Zhao, Jiuqiao; Huang, Lisa; Sheriff, Steven; Yan, C...
Journal:
Bioorganic & medicinal chemistry letters
Issue:
Volume 51(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Preclinical Pharmacokinetics and In Vitro Metabolism of Asunaprevir (BMS‐650032), a Potent Hepatitis C Virus NS3 Protease Inhibitor. Issue 9 (28th January 2015)

Authors:
Mosure, Kathleen W.; Knipe, Jay O.; Browning, Marc; Arora, Vinod; Shu, Yue‐Zhong; Phillip, Thomas; Mcphee, Fiona; Scola, Paul; Balakrishnan, Anand; Soars, Matthew G.; Santone, Kenneth; Sinz, Michael; Donovan, Maureen D.; Langguth, Peter; Polli, James E.; Tamai, Ikumi; Vig, Balvinder; Yu, Lawrence X.
Journal:
Journal of pharmaceutical sciences
Issue:
Volume 104:Issue 9(2015:Sep.)
Page Start:
2813
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗